["{\n\"step_by_step_thinking\": \"The patient has failed metformin therapy, which is a first-line medication for type 2 diabetes. Considering her history of pancreatitis, it's likely she has type 2 diabetes. She also doesn't want to take injections, so oral medications are preferred. The provided options are all oral medications commonly used in the treatment of type 2 diabetes.\n\nCanagliflozin and liraglutide are both SGLT-2 inhibitors, which can increase the risk of pancreatitis. Given her history of pancreatitis, these medications would not be suitable for this patient.\n\nSitagliptin is a DPP-4 inhibitor that does not have any direct link to pancreatitis or bladder cancer. It's a safe option considering her medical history.\n\nPioglitazone is a thiazolidinedione (TZD) that can increase the risk of bladder cancer, which is concerning given her family history of bladder cancer. Therefore, it would not be a suitable option for this patient.\n\nConsidering these points, Sitagliptin would be the most appropriate choice to reduce her glucose levels.\", \n\"answer_choice\": \"B\""]